menu
    • menu

    Company profile for ASC Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT™ and other gene editing technologies developed after 12 years of R&D at Applied Stem Cells, Inc. The company’s therapeutic development pipeline includes several preclinical stage programs in gene and cell therapy progressing int...
    ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT™ and other gene editing technologies developed after 12 years of R&D at Applied Stem Cells, Inc. The company’s therapeutic development pipeline includes several preclinical stage programs in gene and cell therapy progressing into clinical stage in 2022 focusing on several blood disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ASC TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    521 Cottonwood Dr, Milpitas, CA 95035
    Telephone
    Telephone
    888 808 0280
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.asctherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/asc-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASC Therapeutics Doses First Patient with ASC618 Gene Therapy
    ASC Therapeutics Doses First Patient with ASC618 Gene Therapy

    29 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231128715945/en

    BUSINESSWIRE
    29 Nov 2023
    Share Share
    Charles River, ASC Therapeutics to Scale Manufacturing of 2nd Gen Gene Therapy
    Charles River, ASC Therapeutics to Scale Manufacturing of 2nd Gen Gene Therapy

    13 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220613005083/en

    BUSINESSWIRE
    13 Jun 2022
    Share Share
    ASC Therapeutics Joins U.S. Consortium of Gene Therapy Partners
    ASC Therapeutics Joins U.S. Consortium of Gene Therapy Partners

    24 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220524006158/en

    BUSINESSWIRE
    24 May 2022
    Share Share
    ASC Tx Announces Podium, Poster Presentations of IND-Enabling Studies for ASC618
    ASC Tx Announces Podium, Poster Presentations of IND-Enabling Studies for ASC618

    16 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220516005908/en

    BUSINESSWIRE
    16 May 2022
    Share Share
    ASC Tx Receives Key Regulatory Designations in U.S. and Europe for Hemophilia A
    ASC Tx Receives Key Regulatory Designations in U.S. and Europe for Hemophilia A

    29 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220329005272/en

    BUSINESSWIRE
    29 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search